TY - JOUR
T1 - Status report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society - Part 3
T2 - Current perspectives on skin and soft tissue infections with emphasis on methicillin-resistant Staphylococcus aureus, commonly encountered scenarios when antibiotic use may not be needed, and concluding remarks on rational use of antibiotics in dermatology
AU - Del Rosso, James Q.
AU - Rosen, Ted
AU - Thiboutot, Diane
AU - Webster, Guy F.
AU - Gallo, Richard L.
AU - Leyden, James J.
AU - Walker, Clay
AU - Zhanel, George
AU - Eichenfield, Lawrence
N1 - Funding Information:
This article was written solely by the authors. Prior to journal submission, the article was reviewed by the AARS Board of Directors and the AARS Education Committee. There was no review or contribution to the authorship of this article by individuals from any company or agency of any company. The subjects included in the content of this article were presented at the third SPAUD Meeting held in Las Vegas, Nevada in September 2014 by the authors of this article series. The content of the presentations at the SPAUD meeting were developed solely by the authors. Physician Resources provided support with literature searches and article procurement, audiovisual needs, and logistical support for the meeting, which was funded by educational grants from Galderma, Allergan, Valeant, Bayer, and Promius.
Publisher Copyright:
© 2016, Matrix Medical Communications. All rights reserved.
PY - 2016/6
Y1 - 2016/6
N2 - In this third article of the three-part series, management of skin and soft tissue infections is reviewed with emphasis on new information on methicillin-resistant Staphylococcus aureus. Due to changes in the evolution of methicillin-resistant Staphylococcus aureus clones, previous distinctions between healthcare-acquired methicillin-resistant Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus are currently much less clinically relevant. Many nosocomial cases of methicillin-resistant Staphylococcus aureus infection are now caused by community-acquired methicillin-resistant Staphylococcus aureus, with changing patterns of antibiotic susceptibility and resistance. Also reviewed are clinical scenarios where antibiotics may not be needed and suggestions for optimal use of antibiotic therapy for dermatologic conditions, including recommendations on perioperative antibiotic use.
AB - In this third article of the three-part series, management of skin and soft tissue infections is reviewed with emphasis on new information on methicillin-resistant Staphylococcus aureus. Due to changes in the evolution of methicillin-resistant Staphylococcus aureus clones, previous distinctions between healthcare-acquired methicillin-resistant Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus are currently much less clinically relevant. Many nosocomial cases of methicillin-resistant Staphylococcus aureus infection are now caused by community-acquired methicillin-resistant Staphylococcus aureus, with changing patterns of antibiotic susceptibility and resistance. Also reviewed are clinical scenarios where antibiotics may not be needed and suggestions for optimal use of antibiotic therapy for dermatologic conditions, including recommendations on perioperative antibiotic use.
UR - http://www.scopus.com/inward/record.url?scp=84975865497&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84975865497&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84975865497
SN - 1941-2789
VL - 9
SP - 17
EP - 24
JO - Journal of Clinical and Aesthetic Dermatology
JF - Journal of Clinical and Aesthetic Dermatology
IS - 6
ER -